Carbonic Anhydrase Inhibitors. Comparison of Chlorthalidone and Indapamide X-ray Crystal Structures in Adducts with Isozyme II: When Three Water Molecules and the Keto−Enol Tautomerism Make the Difference

Thiazide diuretics inhibit all mammalian isoforms of carbonic anhydrase (CA, EC 4.2.1.1) with a different profile as compared to classical inhibitors. Acting as moderate-weak inhibitors of CA II and CA I, chlorthalidone and indapamide considerably inhibit other isozymes among the 16 CAs present in v...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Journal of medicinal chemistry 2009-01, Vol.52 (2), p.322-328
Hauptverfasser: Temperini, Claudia, Cecchi, Alessandro, Scozzafava, Andrea, Supuran, Claudiu T
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 328
container_issue 2
container_start_page 322
container_title Journal of medicinal chemistry
container_volume 52
creator Temperini, Claudia
Cecchi, Alessandro
Scozzafava, Andrea
Supuran, Claudiu T
description Thiazide diuretics inhibit all mammalian isoforms of carbonic anhydrase (CA, EC 4.2.1.1) with a different profile as compared to classical inhibitors. Acting as moderate-weak inhibitors of CA II and CA I, chlorthalidone and indapamide considerably inhibit other isozymes among the 16 CAs present in vertebrates. These compounds show a different behavior against CAs I and II, with chlorthalidone being 18.3 times more potent against CA II and 150 times more potent against CA I, as compared to indapamide. In the X-ray crystal structures of the CA II−chlorthalidone adduct three active site water molecules interacting with the inhibitor scaffold were observed that lack in the corresponding indapamide adduct. Chlorthalidone bound within the active site is in an enolic tautomeric form, with the OH moiety participating in two strong hydrogen bonds with Asn67 and a water molecule. This binding mode may be exploited for designing better CA II inhibitors.
doi_str_mv 10.1021/jm801386n
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_66824190</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>66824190</sourcerecordid><originalsourceid>FETCH-LOGICAL-a343t-d7691348d742915372017bea18a60dd5e137ef224ccc82cd4b4dea1032b260253</originalsourceid><addsrcrecordid>eNpt0U9u1DAUBvAIgehQWHAB5A1ILFL8J3Ey7EahwIhWLBhUdtGL_aJ4cOzBdoTCCVhzMA7BSUjpqN2wsiz__D3LX5Y9ZfSMUc5e7ceaMlFLdy9bsZLTvKhpcT9bUcp5ziUXJ9mjGPeUUsG4eJidsDVjZV2IVfa7gdB5ZxTZuGHWASKSrRtMZ5IP8Yw0fjxAMNE74nvSDNaHNIA12jsk4PSCNRxgNBrJlzzATJowxwSWfEphUmkKGIlxZKP1sovku0kD2Ub_Yx6XQdvX5GpAR3ZDQCRXkDCQS29RTXa5dh2fBiQfMPk_P3-dO2_JDqbkR1xeNJJL-Ir_wBvT9xjQKXycPejBRnxyXE-zz2_Pd837_OLju22zuchBFCLlupJrJopaVwVfs1JUnLKqQ2A1SKp1iUxU2HNeKKVqrnTRFXo5pYJ3XFJeitPsxU3uIfhvE8bUjiYqtBYc-im2Uta8YGu6wJc3UAUfY8C-PQQzQphbRtvr8trb8hb77Bg6dSPqO3lsawHPjwCiAtsHcMrEW8cZlZJLdudAxXbvp-CWv_jPwL9fCrEu</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>66824190</pqid></control><display><type>article</type><title>Carbonic Anhydrase Inhibitors. Comparison of Chlorthalidone and Indapamide X-ray Crystal Structures in Adducts with Isozyme II: When Three Water Molecules and the Keto−Enol Tautomerism Make the Difference</title><source>MEDLINE</source><source>American Chemical Society Journals</source><creator>Temperini, Claudia ; Cecchi, Alessandro ; Scozzafava, Andrea ; Supuran, Claudiu T</creator><creatorcontrib>Temperini, Claudia ; Cecchi, Alessandro ; Scozzafava, Andrea ; Supuran, Claudiu T</creatorcontrib><description>Thiazide diuretics inhibit all mammalian isoforms of carbonic anhydrase (CA, EC 4.2.1.1) with a different profile as compared to classical inhibitors. Acting as moderate-weak inhibitors of CA II and CA I, chlorthalidone and indapamide considerably inhibit other isozymes among the 16 CAs present in vertebrates. These compounds show a different behavior against CAs I and II, with chlorthalidone being 18.3 times more potent against CA II and 150 times more potent against CA I, as compared to indapamide. In the X-ray crystal structures of the CA II−chlorthalidone adduct three active site water molecules interacting with the inhibitor scaffold were observed that lack in the corresponding indapamide adduct. Chlorthalidone bound within the active site is in an enolic tautomeric form, with the OH moiety participating in two strong hydrogen bonds with Asn67 and a water molecule. This binding mode may be exploited for designing better CA II inhibitors.</description><identifier>ISSN: 0022-2623</identifier><identifier>EISSN: 1520-4804</identifier><identifier>DOI: 10.1021/jm801386n</identifier><identifier>PMID: 19115843</identifier><identifier>CODEN: JMCMAR</identifier><language>eng</language><publisher>Columbus, OH: American Chemical Society</publisher><subject>Antihypertensive agents ; Biological and medical sciences ; Carbonic Anhydrase Inhibitors - chemistry ; Carbonic Anhydrase Inhibitors - pharmacology ; Cardiovascular system ; Catalytic Domain ; Chlorthalidone - chemistry ; Chlorthalidone - pharmacology ; Crystallography, X-Ray ; Indapamide - chemistry ; Indapamide - pharmacology ; Isoenzymes - chemistry ; Medical sciences ; Models, Molecular ; Pharmacology. Drug treatments ; Stereoisomerism ; Water - chemistry</subject><ispartof>Journal of medicinal chemistry, 2009-01, Vol.52 (2), p.322-328</ispartof><rights>Copyright © 2009 American Chemical Society</rights><rights>2009 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-a343t-d7691348d742915372017bea18a60dd5e137ef224ccc82cd4b4dea1032b260253</citedby><cites>FETCH-LOGICAL-a343t-d7691348d742915372017bea18a60dd5e137ef224ccc82cd4b4dea1032b260253</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://pubs.acs.org/doi/pdf/10.1021/jm801386n$$EPDF$$P50$$Gacs$$H</linktopdf><linktohtml>$$Uhttps://pubs.acs.org/doi/10.1021/jm801386n$$EHTML$$P50$$Gacs$$H</linktohtml><link.rule.ids>314,776,780,2752,27053,27901,27902,56713,56763</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=21066261$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/19115843$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Temperini, Claudia</creatorcontrib><creatorcontrib>Cecchi, Alessandro</creatorcontrib><creatorcontrib>Scozzafava, Andrea</creatorcontrib><creatorcontrib>Supuran, Claudiu T</creatorcontrib><title>Carbonic Anhydrase Inhibitors. Comparison of Chlorthalidone and Indapamide X-ray Crystal Structures in Adducts with Isozyme II: When Three Water Molecules and the Keto−Enol Tautomerism Make the Difference</title><title>Journal of medicinal chemistry</title><addtitle>J. Med. Chem</addtitle><description>Thiazide diuretics inhibit all mammalian isoforms of carbonic anhydrase (CA, EC 4.2.1.1) with a different profile as compared to classical inhibitors. Acting as moderate-weak inhibitors of CA II and CA I, chlorthalidone and indapamide considerably inhibit other isozymes among the 16 CAs present in vertebrates. These compounds show a different behavior against CAs I and II, with chlorthalidone being 18.3 times more potent against CA II and 150 times more potent against CA I, as compared to indapamide. In the X-ray crystal structures of the CA II−chlorthalidone adduct three active site water molecules interacting with the inhibitor scaffold were observed that lack in the corresponding indapamide adduct. Chlorthalidone bound within the active site is in an enolic tautomeric form, with the OH moiety participating in two strong hydrogen bonds with Asn67 and a water molecule. This binding mode may be exploited for designing better CA II inhibitors.</description><subject>Antihypertensive agents</subject><subject>Biological and medical sciences</subject><subject>Carbonic Anhydrase Inhibitors - chemistry</subject><subject>Carbonic Anhydrase Inhibitors - pharmacology</subject><subject>Cardiovascular system</subject><subject>Catalytic Domain</subject><subject>Chlorthalidone - chemistry</subject><subject>Chlorthalidone - pharmacology</subject><subject>Crystallography, X-Ray</subject><subject>Indapamide - chemistry</subject><subject>Indapamide - pharmacology</subject><subject>Isoenzymes - chemistry</subject><subject>Medical sciences</subject><subject>Models, Molecular</subject><subject>Pharmacology. Drug treatments</subject><subject>Stereoisomerism</subject><subject>Water - chemistry</subject><issn>0022-2623</issn><issn>1520-4804</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2009</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNpt0U9u1DAUBvAIgehQWHAB5A1ILFL8J3Ey7EahwIhWLBhUdtGL_aJ4cOzBdoTCCVhzMA7BSUjpqN2wsiz__D3LX5Y9ZfSMUc5e7ceaMlFLdy9bsZLTvKhpcT9bUcp5ziUXJ9mjGPeUUsG4eJidsDVjZV2IVfa7gdB5ZxTZuGHWASKSrRtMZ5IP8Yw0fjxAMNE74nvSDNaHNIA12jsk4PSCNRxgNBrJlzzATJowxwSWfEphUmkKGIlxZKP1sovku0kD2Ub_Yx6XQdvX5GpAR3ZDQCRXkDCQS29RTXa5dh2fBiQfMPk_P3-dO2_JDqbkR1xeNJJL-Ir_wBvT9xjQKXycPejBRnxyXE-zz2_Pd837_OLju22zuchBFCLlupJrJopaVwVfs1JUnLKqQ2A1SKp1iUxU2HNeKKVqrnTRFXo5pYJ3XFJeitPsxU3uIfhvE8bUjiYqtBYc-im2Uta8YGu6wJc3UAUfY8C-PQQzQphbRtvr8trb8hb77Bg6dSPqO3lsawHPjwCiAtsHcMrEW8cZlZJLdudAxXbvp-CWv_jPwL9fCrEu</recordid><startdate>20090122</startdate><enddate>20090122</enddate><creator>Temperini, Claudia</creator><creator>Cecchi, Alessandro</creator><creator>Scozzafava, Andrea</creator><creator>Supuran, Claudiu T</creator><general>American Chemical Society</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7X8</scope></search><sort><creationdate>20090122</creationdate><title>Carbonic Anhydrase Inhibitors. Comparison of Chlorthalidone and Indapamide X-ray Crystal Structures in Adducts with Isozyme II: When Three Water Molecules and the Keto−Enol Tautomerism Make the Difference</title><author>Temperini, Claudia ; Cecchi, Alessandro ; Scozzafava, Andrea ; Supuran, Claudiu T</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-a343t-d7691348d742915372017bea18a60dd5e137ef224ccc82cd4b4dea1032b260253</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2009</creationdate><topic>Antihypertensive agents</topic><topic>Biological and medical sciences</topic><topic>Carbonic Anhydrase Inhibitors - chemistry</topic><topic>Carbonic Anhydrase Inhibitors - pharmacology</topic><topic>Cardiovascular system</topic><topic>Catalytic Domain</topic><topic>Chlorthalidone - chemistry</topic><topic>Chlorthalidone - pharmacology</topic><topic>Crystallography, X-Ray</topic><topic>Indapamide - chemistry</topic><topic>Indapamide - pharmacology</topic><topic>Isoenzymes - chemistry</topic><topic>Medical sciences</topic><topic>Models, Molecular</topic><topic>Pharmacology. Drug treatments</topic><topic>Stereoisomerism</topic><topic>Water - chemistry</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Temperini, Claudia</creatorcontrib><creatorcontrib>Cecchi, Alessandro</creatorcontrib><creatorcontrib>Scozzafava, Andrea</creatorcontrib><creatorcontrib>Supuran, Claudiu T</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>MEDLINE - Academic</collection><jtitle>Journal of medicinal chemistry</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Temperini, Claudia</au><au>Cecchi, Alessandro</au><au>Scozzafava, Andrea</au><au>Supuran, Claudiu T</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Carbonic Anhydrase Inhibitors. Comparison of Chlorthalidone and Indapamide X-ray Crystal Structures in Adducts with Isozyme II: When Three Water Molecules and the Keto−Enol Tautomerism Make the Difference</atitle><jtitle>Journal of medicinal chemistry</jtitle><addtitle>J. Med. Chem</addtitle><date>2009-01-22</date><risdate>2009</risdate><volume>52</volume><issue>2</issue><spage>322</spage><epage>328</epage><pages>322-328</pages><issn>0022-2623</issn><eissn>1520-4804</eissn><coden>JMCMAR</coden><abstract>Thiazide diuretics inhibit all mammalian isoforms of carbonic anhydrase (CA, EC 4.2.1.1) with a different profile as compared to classical inhibitors. Acting as moderate-weak inhibitors of CA II and CA I, chlorthalidone and indapamide considerably inhibit other isozymes among the 16 CAs present in vertebrates. These compounds show a different behavior against CAs I and II, with chlorthalidone being 18.3 times more potent against CA II and 150 times more potent against CA I, as compared to indapamide. In the X-ray crystal structures of the CA II−chlorthalidone adduct three active site water molecules interacting with the inhibitor scaffold were observed that lack in the corresponding indapamide adduct. Chlorthalidone bound within the active site is in an enolic tautomeric form, with the OH moiety participating in two strong hydrogen bonds with Asn67 and a water molecule. This binding mode may be exploited for designing better CA II inhibitors.</abstract><cop>Columbus, OH</cop><pub>American Chemical Society</pub><pmid>19115843</pmid><doi>10.1021/jm801386n</doi><tpages>7</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0022-2623
ispartof Journal of medicinal chemistry, 2009-01, Vol.52 (2), p.322-328
issn 0022-2623
1520-4804
language eng
recordid cdi_proquest_miscellaneous_66824190
source MEDLINE; American Chemical Society Journals
subjects Antihypertensive agents
Biological and medical sciences
Carbonic Anhydrase Inhibitors - chemistry
Carbonic Anhydrase Inhibitors - pharmacology
Cardiovascular system
Catalytic Domain
Chlorthalidone - chemistry
Chlorthalidone - pharmacology
Crystallography, X-Ray
Indapamide - chemistry
Indapamide - pharmacology
Isoenzymes - chemistry
Medical sciences
Models, Molecular
Pharmacology. Drug treatments
Stereoisomerism
Water - chemistry
title Carbonic Anhydrase Inhibitors. Comparison of Chlorthalidone and Indapamide X-ray Crystal Structures in Adducts with Isozyme II: When Three Water Molecules and the Keto−Enol Tautomerism Make the Difference
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-04T13%3A00%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Carbonic%20Anhydrase%20Inhibitors.%20Comparison%20of%20Chlorthalidone%20and%20Indapamide%20X-ray%20Crystal%20Structures%20in%20Adducts%20with%20Isozyme%20II:%20When%20Three%20Water%20Molecules%20and%20the%20Keto%E2%88%92Enol%20Tautomerism%20Make%20the%20Difference&rft.jtitle=Journal%20of%20medicinal%20chemistry&rft.au=Temperini,%20Claudia&rft.date=2009-01-22&rft.volume=52&rft.issue=2&rft.spage=322&rft.epage=328&rft.pages=322-328&rft.issn=0022-2623&rft.eissn=1520-4804&rft.coden=JMCMAR&rft_id=info:doi/10.1021/jm801386n&rft_dat=%3Cproquest_cross%3E66824190%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=66824190&rft_id=info:pmid/19115843&rfr_iscdi=true